BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26865261)

  • 1. Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.
    Ahn PH; Quon H; O'Malley BW; Weinstein G; Chalian A; Malloy K; Atkins JH; Sollecito T; Greenberg M; McNulty S; Lin A; Zhu TC; Finlay JC; Cengel K; Livolsi V; Feldman M; Mick R; Busch TM
    Oral Oncol; 2016 Apr; 55():37-42. PubMed ID: 26865261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy.
    Ahn PH; Finlay JC; Gallagher-Colombo SM; Quon H; O'Malley BW; Weinstein GS; Chalian A; Malloy K; Sollecito T; Greenberg M; Simone CB; McNulty S; Lin A; Zhu TC; Livolsi V; Feldman M; Mick R; Cengel KA; Busch TM
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():28-35. PubMed ID: 29113960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
    Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Hsu YC; Yang DF; Chiang CP; Lee JW; Tseng MK
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):310-8. PubMed ID: 23200011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photodynamic therapy of early squamous epithelial carcinomas and severe squamous epithelial dysplasias of the esophagus with 5-aminolevulinic acid].
    Gossner L; Stolte M; Sroka R; May A; Hahn EG; Ell C
    Z Gastroenterol; 1998 Jan; 36(1):19-26. PubMed ID: 9531686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity.
    Fan KF; Hopper C; Speight PM; Buonaccorsi G; MacRobert AJ; Bown SG
    Cancer; 1996 Oct; 78(7):1374-83. PubMed ID: 8839541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration.
    Quon H; Grossman CE; King RL; Putt M; Donaldson K; Kricka L; Finlay J; Zhu T; Dimofte A; Malloy K; Cengel KA; Busch TM
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):268-74. PubMed ID: 21112550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for head and neck lesions in the subtropics.
    Civantos F
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S65-8. PubMed ID: 23055220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
    Yang DF; Lee JW; Chen HM; Hsu YC
    J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP
    Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminolevulinic acid photodynamic therapy for early-stage lip squamous cell carcinoma.
    Wang P; Zhang G; Zhang L; Zhou Z; Shi L; Zeng Q; Zhu L; Wang X
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102321. PubMed ID: 34015543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vitro sensitivity of oral precancerous and squamous cell carcinoma cell lines to 5-aminolevulinic acid-mediated photodynamic therapy.
    Wang X; Jin J; Li W; Wang Q; Han Y; Liu H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101554. PubMed ID: 31479802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
    Gossner L; May A; Sroka R; Ell C
    Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
    Lang K; Schulte KW; Ruzicka T; Fritsch C
    Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy in head and neck cancer: indications, outcomes, and future prospects.
    Meulemans J; Delaere P; Vander Poorten V
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):136-141. PubMed ID: 30724766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.